Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Siegrist Claire-Anne"" wg kryterium: Autor


Tytuł:
Refined innate plasma signature after rVSVDGZEBOV-GP immunization is shared among adult cohorts in Europe and North America.
Autorzy:
Martinez-Murillo, Paola Andrea
Huttner, Angela
Lemeille, Sylvain
Medaglini, Donata
Ottenhoff, Tom H. M.
Harandi, Ali M.
Didierlaurent, Arnaud M.
Siegrist, Claire-Anne
Pokaż więcej
Temat:
NEUTRALIZATION tests
VACCINE effectiveness
VESICULAR stomatitis
PRINCIPAL components analysis
ANTIBODY titer
EBOLA virus
Źródło:
Frontiers in Immunology; 2024, p1-15, 15p
Terminy geograficzne:
GENEVA (Switzerland)
Czasopismo naukowe
Tytuł:
Influence of circadian clocks on adaptive immunity and vaccination responses
Autorzy:
Ince, Louise MadeleineAff1, Aff13
Barnoud, Coline
Lutes, Lydia Kay
Pick, Robert
Wang, Chen
Sinturel, FloreAff2, Aff3, Aff4, Aff5
Chen, Chien-Sin
de Juan, Alba
Weber, Jasmin
Holtkamp, Stephan J.
Hergenhan, Sophia Martina
Geddes-McAlister, JenniferAff7, Aff14
Ebner, StefanAff7, Aff8
Fontannaz, PaolaAff1, Aff9
Meyer, BenjaminAff1, Aff9
Vono, MariaAff1, Aff9
Jemelin, Stéphane
Dibner, CharnaAff2, Aff3, Aff4, Aff5
Siegrist, Claire-AnneAff1, Aff9
Meissner, FelixAff7, Aff8
Graw, FrederikAff10, Aff11
Scheiermann, ChristophAff1, Aff5, Aff6, Aff12, IDs41467023359792_cor22
Pokaż więcej
Źródło:
Nature Communications. 14(1)
Czasopismo naukowe
Tytuł:
C-type lectin receptor agonists elicit functional IL21-expressing Tfh cells and induce primary B cell responses in neonates.
Autorzy:
Vono, Maria
Mastelic-Gavillet, Beatris
Mohr, Elodie
Östensson, Malin
Persson, Josefine
Olafsdottir, Thorunn A.
Lemeille, Sylvain
Pejoski, David
Hartley, Oliver
Christensen, Dennis
Andersen, Peter
Didierlaurent, Arnaud M.
Harandi, Ali M.
Lambert, Paul-Henri
Siegrist, Claire-Anne
Pokaż więcej
Temat:
B cells
T cells
NEWBORN infants
TOLL-like receptors
GERMINAL centers
Źródło:
Frontiers in Immunology; 3/31/2023, Vol. 14, p1-14, 14p
Czasopismo naukowe
Czasopismo naukowe
Tytuł:
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs
Autorzy:
Bekliz, Meriem
Adea, Kenneth
Vetter, PaulineAff2, Aff3
Eberhardt, Christiane S.Aff4, Aff5, Aff6
Hosszu-Fellous, KrisztinaAff2, Aff3
Vu, Diem-Lan
Puhach, Olha
Essaidi-Laziosi, Manel
Waldvogel-Abramowski, Sophie
Stephan, Caroline
L’Huillier, Arnaud G.
Siegrist, Claire-Anne
Didierlaurent, Arnaud M.
Kaiser, LaurentAff2, Aff3
Meyer, BenjaminAff4, IDs41467022315561_cor15
Eckerle, IsabellaAff1, Aff2, Aff3, IDs41467022315561_cor16
Pokaż więcej
Źródło:
Nature Communications. 13(1)
Czasopismo naukowe
Tytuł:
Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistence.
Autorzy:
L'Huillier AG; Department of Woman, Pediatric Infectious Diseases Unit, Child and Adolescent Medicine, Geneva University Hospitals and Geneva University, Geneva, Switzerland.; Division of Laboratory Medicine, Department of Diagnostics and of Medical Specialties, Geneva University Hospitals and Geneva University, Geneva, Switzerland.
Pagano S; Division of Laboratory Medicine, Department of Diagnostics and of Medical Specialties, Geneva University Hospitals and Geneva University, Geneva, Switzerland.
Baggio S; Division of Prison Health, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.; Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Meyer B; Centre for Vaccinology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
Andrey DO; Division of Laboratory Medicine, Department of Diagnostics and of Medical Specialties, Geneva University Hospitals and Geneva University, Geneva, Switzerland.; Division of Infectious Diseases, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland.
Nehme M; Division of Primary Care Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
Guessous I; Division of Primary Care Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
Eberhardt CS; Centre for Vaccinology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
Huttner A; Centre for Vaccinology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.; Division of Infectious Diseases, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland.
Posfay-Barbe KM; Department of Woman, Pediatric Infectious Diseases Unit, Child and Adolescent Medicine, Geneva University Hospitals and Geneva University, Geneva, Switzerland.
Yerly S; Division of Laboratory Medicine, Department of Diagnostics and of Medical Specialties, Geneva University Hospitals and Geneva University, Geneva, Switzerland.
Siegrist CA; Centre for Vaccinology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
Kaiser L; Division of Laboratory Medicine, Department of Diagnostics and of Medical Specialties, Geneva University Hospitals and Geneva University, Geneva, Switzerland.; Division of Infectious Diseases, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland.; Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland.
Vuilleumier N; Division of Laboratory Medicine, Department of Diagnostics and of Medical Specialties, Geneva University Hospitals and Geneva University, Geneva, Switzerland.
Pokaż więcej
Źródło:
European journal of clinical investigation [Eur J Clin Invest] 2022 Oct; Vol. 52 (10), pp. e13818. Date of Electronic Publication: 2022 Jun 02.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*
Antibodies, Viral ; Antiviral Agents ; Apolipoprotein A-I ; Autoantibodies ; Humans ; SARS-CoV-2
Czasopismo naukowe
Tytuł:
Replication-Deficient Lymphocytic Choriomeningitis Virus-Vectored Vaccine Candidate for the Induction of T Cell Immunity against Mycobacterium tuberculosis.
Autorzy:
Belnoue, Elodie
Vogelzang, Alexis
Nieuwenhuizen, Natalie E.
Krzyzaniak, Magdalena A.
Darbre, Stephanie
Kreutzfeldt, Mario
Wagner, Ingrid
Merkler, Doron
Lambert, Paul-Henri
Kaufmann, Stefan H. E.
Siegrist, Claire-Anne
Pinschewer, Daniel D.
Pokaż więcej
Temat:
T cells
LYMPHOCYTIC choriomeningitis
MYCOBACTERIUM tuberculosis
LYMPHOCYTIC choriomeningitis virus
TUBERCULOSIS
BCG vaccines
Źródło:
International Journal of Molecular Sciences; Mar2022, Vol. 23 Issue 5, p2700, 1p
Czasopismo naukowe
Tytuł:
SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1.
Autorzy:
Pagano S; Division of Laboratory Medicine, Department of Diagnostics and of Medical Specialties, Geneva University Hospitals and Geneva University, Geneva, Switzerland.
Yerly S; Division of Laboratory Medicine, Department of Diagnostics and of Medical Specialties, Geneva University Hospitals and Geneva University, Geneva, Switzerland.
Meyer B; Centre for Vaccinology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
Juillard C; Division of Laboratory Medicine, Department of Diagnostics and of Medical Specialties, Geneva University Hospitals and Geneva University, Geneva, Switzerland.
Suh N; Division of Intensive Care, Geneva University Hospitals and the University of Geneva Faculty of Medicine, Geneva, Switzerland.
Le Terrier C; Division of Intensive Care, Geneva University Hospitals and the University of Geneva Faculty of Medicine, Geneva, Switzerland.
Daguer JP; Faculty of Science, Department of Organic Chemistry, NCCR Chemical Biology, University of Geneva, Geneva, Switzerland.
Farrera-Soler L; Faculty of Science, Department of Organic Chemistry, NCCR Chemical Biology, University of Geneva, Geneva, Switzerland.
Barluenga S; Faculty of Science, Department of Organic Chemistry, NCCR Chemical Biology, University of Geneva, Geneva, Switzerland.
Piumatti G; Division and Department of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.; Faculty of BioMedicine, Università della Svizzera Italiana, Lugano, Switzerland.
Hartley O; Faculty of Medicine, Department of Pathology and Immunology, University of Geneva, Switzerland.
Lemaitre B; Division of Laboratory Medicine, Department of Diagnostics and of Medical Specialties, Geneva University Hospitals and Geneva University, Geneva, Switzerland.
Eberhardt CS; Faculty of Medicine, Departments of Pathology-Immunology and Pediatrics, University of Geneva, Geneva, Switzerland.
Siegrist CA; Division of Laboratory Medicine, Department of Diagnostics and of Medical Specialties, Geneva University Hospitals and Geneva University, Geneva, Switzerland.; Faculty of Medicine, Departments of Pathology-Immunology and Pediatrics, University of Geneva, Geneva, Switzerland.
Eckerle I; Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland.
Stringhini S; Division and Department of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.; Unit of Population Epidemiology, Division of Primary Care, Geneva University Hospitals, Geneva, Switzerland.
Guessous I; Division and Department of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.
Kaiser L; Division of Laboratory Medicine, Department of Diagnostics and of Medical Specialties, Geneva University Hospitals and Geneva University, Geneva, Switzerland.; Faculty of Medicine, Departments of Pathology-Immunology and Pediatrics, University of Geneva, Geneva, Switzerland.; Division of Infectious Diseases, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland.
Pugin J; Division of Intensive Care, Geneva University Hospitals and the University of Geneva Faculty of Medicine, Geneva, Switzerland.
Winssinger N; Faculty of Science, Department of Organic Chemistry, NCCR Chemical Biology, University of Geneva, Geneva, Switzerland.
Vuilleumier N; Division of Laboratory Medicine, Department of Diagnostics and of Medical Specialties, Geneva University Hospitals and Geneva University, Geneva, Switzerland.
Pokaż więcej
Źródło:
European journal of clinical investigation [Eur J Clin Invest] 2021 Nov; Vol. 51 (11), pp. e13661. Date of Electronic Publication: 2021 Aug 04.
Typ publikacji:
Journal Article
MeSH Terms:
Antibodies, Viral/*immunology
Apolipoprotein A-I/*immunology
Autoantibodies/*immunology
COVID-19/*immunology
Cytokines/*immunology
Immunity, Humoral/*immunology
Spike Glycoprotein, Coronavirus/*immunology
Adult ; Aged ; Aged, 80 and over ; Apolipoprotein A-I/chemistry ; Computational Biology ; Epitopes/chemistry ; Female ; Humans ; Immunoglobulin G/immunology ; Male ; Middle Aged ; Peptide Fragments/chemistry ; Peptide Fragments/immunology ; Peptides ; SARS-CoV-2 ; Sequence Homology, Amino Acid ; Spike Glycoprotein, Coronavirus/chemistry ; Toll-Like Receptor 2/chemistry ; Toll-Like Receptor 2/immunology ; Young Adult
Czasopismo naukowe
Tytuł:
Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of Symptoms
Autorzy:
Vu, Diem-LanAff1, Aff2, Aff3, IDs1087502101134z_cor1
Martinez-Murillo, Paola
Pigny, FionaAff2, Aff3
Vono, Maria
Meyer, Benjamin
Eberhardt, Christiane S.Aff3, Aff4
Lemeille, Sylvain
Von Dach, ElodieAff1, Aff3
Blanchard-Rohner, GéraldineAff4, Aff5
Eckerle, IsabellaAff1, Aff2, Aff6, Aff7
Huttner, AngelaAff1, Aff3, Aff4
Siegrist, Claire-AnneAff3, Aff4
Kaiser, LaurentAff1, Aff2, Aff3, Aff6
Didierlaurent, Arnaud M.Aff4, Aff6, IDs1087502101134z_cor14
Pokaż więcej
Źródło:
Journal of Clinical Immunology: International Journal of Inborn Errors of Immunity and Related Diseases. 41(8):1723-1732
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies